What is the market price of a box of serputinib/serpatinib?

Selpercatinib (Selpercatinib), as a targeted drug targeting RET gene mutations and fusions, has been officially launched in China, but it has not yet been included in the medical insurance catalog, which means that patients need to bear all costs. Taking the 80mg specification and 56 capsules as an example, the market price of a box of Seputinib is expected to exceed RMB 10,000. Due to the lack of medical insurance support, patients need to consider high financial pressure when using it.

In overseas markets, the price of the original drug of Seputinib is relatively higher, usually between 20,000 and 100,000 yuan. The specific price will change according to exchange rate fluctuations. High prices limit access to some patients, leaving many patients and families facing a certain financial burden when choosing treatment options. Despite this, seputinib remains an important treatment option for patients with RET related cancers due to its good therapeutic effect.

In order to solve the price problem, generic drugs of seputinib have appeared in overseas markets. The ingredients of these generic drugs are basically the same as those of the original drug and can provide patients with the same therapeutic effect. Take the generic drugs produced by Laos Pharmaceutical Factory as an example. The specification is 40mg*120 tablets. The price is only more than 2,000 yuan. The price advantage is obvious, which greatly reduces the financial burden of patients and enables more patients to receive effective treatment.

In general, although the original drug of Seputinib is more expensive domestically and overseas, the emergence of generic drugs has brought more choices to patients. When taking medication, patients should reasonably choose the appropriate version of the medication based on their own financial situation and treatment needs, combined with doctor's advice, to ensure the continuity and effect of treatment.

Reference materials:https://en.wikipedia.org/wiki/Selpercatinib